Last 12 months
Inside the activity.
2 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 7 |
| Jul 2026 | 1 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 9 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 22, 2020 Filed May 27, 2020 20:32 UTC |
PEARSON TIMOTHY RDirector
|
GrantStock Option (right to buy) · Derivative | 21,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001209191-20-032311 · doc4.xml · derivative · entry 1 PEARSON TIMOTHY R · CIK 0001528617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires 2030-05-21 F1 · derivative.exercise_date: The shares underlying this option vest on May 22, 2021, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| May 22, 2020 Filed May 27, 2020 20:31 UTC |
Koenig ScottDirector
|
GrantStock Option (right to buy) · Derivative | 21,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001209191-20-032308 · doc4.xml · derivative · entry 1 Koenig Scott · CIK 0001587514 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires 2030-05-21 F1 · derivative.exercise_date: The shares underlying this option vest on May 22, 2021, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| May 22, 2020 Filed May 27, 2020 20:29 UTC |
Jackson Scott ThomasDirector
|
GrantStock Option (right to buy) · Derivative | 21,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001209191-20-032304 · doc4.xml · derivative · entry 1 Jackson Scott Thomas · CIK 0001566617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires 2030-05-21 F1 · derivative.exercise_date: The shares underlying this option vest on May 22, 2021, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| May 22, 2020 Filed May 27, 2020 20:28 UTC |
Goldberg Mark AlanDirector
|
GrantStock Option (right to buy) · Derivative | 21,000 | $0.00 Strike: $3.00 | $0.00 |
DisclosureSEC source: 0001209191-20-032302 · doc4.xml · derivative · entry 1 Goldberg Mark Alan · CIK 0001532475 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires 2030-05-21 F1 · derivative.exercise_date: The shares underlying this option vest on May 22, 2021, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| March 09, 2020 Filed Mar 10, 2020 22:12 UTC |
JUNIUS DANIEL MDirector
|
PurchaseCommon Stock | 20,000 | $3.40 | $68,000.00 |
DisclosureSEC source: 0001209191-20-017836 · doc4.xml · nonDerivative · entry 1 JUNIUS DANIEL M · CIK 0001094159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,000 F1 · price: The Reporting Person purchased the securities on the open market at purchase prices ranging from $3.40 to $3.41 per share, with a weighted average purchase price of $3.40 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| January 22, 2020 Filed Jan 24, 2020 21:23 UTC |
Girard ArmandSVP, Chief Business Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $4.72 | $0.00 |
DisclosureSEC source: 0001209191-20-004828 · doc4.xml · derivative · entry 1 Girard Armand · CIK 0001769636 · SVP, Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-01-21 F1 · derivative.exercise_date: One-fourth of the shares underlying this option vest on January 22, 2021 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date. Read SEC document |
| January 22, 2020 Filed Jan 24, 2020 21:22 UTC |
Magnani John L.SVP of Research, CSO
|
GrantEmployee Stock Option (right to buy) · Derivative | 120,000 | $0.00 Strike: $4.72 | $0.00 |
DisclosureSEC source: 0001209191-20-004826 · doc4.xml · derivative · entry 1 Magnani John L. · CIK 0001589713 · SVP of Research, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2030-01-21 F1 · derivative.exercise_date: One-fourth of the shares underlying this option vest on January 22, 2021 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date. Read SEC document |
| January 22, 2020 Filed Jan 24, 2020 21:20 UTC |
Hahn Brian M.SVP Finance, CFO
|
GrantEmployee Stock Option (right to buy) · Derivative | 120,000 | $0.00 Strike: $4.72 | $0.00 |
DisclosureSEC source: 0001209191-20-004824 · doc4.xml · derivative · entry 1 Hahn Brian M. · CIK 0001589711 · SVP Finance, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2030-01-21 F1 · derivative.exercise_date: One-fourth of the shares underlying this option vest on January 22, 2021 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date. Read SEC document |
| January 22, 2020 Filed Jan 24, 2020 21:17 UTC |
Thackray Helen M.SVP Clinical Development, CMO
|
GrantEmployee Stock Option (right to buy) · Derivative | 120,000 | $0.00 Strike: $4.72 | $0.00 |
DisclosureSEC source: 0001209191-20-004818 · doc4.xml · derivative · entry 1 Thackray Helen M. · CIK 0001589725 · SVP Clinical Development, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2030-01-21 F1 · derivative.exercise_date: One-fourth of the shares underlying this option vest on January 22, 2021 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date. Read SEC document |
| January 22, 2020 Filed Jan 24, 2020 21:14 UTC |
King Rachel K.Director · President, CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 349,000 | $0.00 Strike: $4.72 | $0.00 |
DisclosureSEC source: 0001209191-20-004814 · doc4.xml · derivative · entry 1 King Rachel K. · CIK 0001589712 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 349,000 Underlying: Common Stock · 349,000 shares Expires 2030-01-21 F1 · derivative.exercise_date: One-fourth of the shares underlying this option vest on January 22, 2021 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date. Read SEC document |
| January 06, 2020 Filed Jan 6, 2020 23:23 UTC |
Magnani John L.SVP of Research, CSO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 106,983 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001209191-20-002098 · doc4.xml · derivative · entry 3 Magnani John L. · CIK 0001589713 · SVP of Research, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 106,983 shares Expires 2021-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One-fourth of the shares underlying this option vested on January 4, 2012, with the remainder vesting in 36 equal monthly installments thereafter. Read SEC document |
| January 06, 2020 Filed Jan 6, 2020 23:23 UTC |
Magnani John L.SVP of Research, CSO
|
Exercise / conversionCommon Stock | 106,983 | $1.12 | $119,820.96 |
DisclosureSEC source: 0001209191-20-002098 · doc4.xml · nonDerivative · entry 1 Magnani John L. · CIK 0001589713 · SVP of Research, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289,760 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 20, 2019 Filed Dec 23, 2019 21:13 UTC |
Magnani John L.SVP of Research, CSO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 106,984 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001209191-19-061782 · doc4.xml · derivative · entry 3 Magnani John L. · CIK 0001589713 · SVP of Research, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,983 Underlying: Common Stock · 106,984 shares Expires 2021-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: One-fourth of the shares underlying this option vested on January 4, 2012, with the remainder vesting in 36 equal monthly installments thereafter. Read SEC document |
| December 20, 2019 Filed Dec 23, 2019 21:13 UTC |
Magnani John L.SVP of Research, CSO
|
Exercise / conversionCommon Stock | 106,984 | $1.12 | $119,822.08 |
DisclosureSEC source: 0001209191-19-061782 · doc4.xml · nonDerivative · entry 1 Magnani John L. · CIK 0001589713 · SVP of Research, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,777 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 20:49 UTC |
BVF PARTNERS L P/IL10% owner
BIOTECHNOLOGY VALUE FUND L PSee Explanation of Responses
BIOTECHNOLOGY VALUE FUND II LPSee Explanation of Responses
Biotechnology Value Trading Fund OS LPSee Explanation of Responses
BVF Partners OS Ltd.See Explanation of Responses
BVF INC/IL10% owner
LAMPERT MARK N10% owner
|
PurchaseCommon Stock, $0.001 par value | 124,956 | $3.18 | $397,609.99 |
DisclosureSEC source: 0000921895-19-002381 · form407422010_09092019.xml · nonDerivative · entry 3 BVF PARTNERS L P/IL · CIK 0001055947 · 10% owner BIOTECHNOLOGY VALUE FUND L P · CIK 0000918923 · See Explanation of Responses BIOTECHNOLOGY VALUE FUND II LP · CIK 0001102444 · See Explanation of Responses Biotechnology Value Trading Fund OS LP · CIK 0001660683 · See Explanation of Responses BVF Partners OS Ltd. · CIK 0001660684 · See Explanation of Responses BVF INC/IL · CIK 0001056807 · 10% owner LAMPERT MARK N · CIK 0001233840 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 528,891 F1 · security: This Form 4 is filed jointly by Biotechnology Value Fund, L.P. ("BVF"), Biotechnology Value Fund II, L.P. ("BVF2"), Biotechnology Value Trading Fund OS LP ("Trading Fund OS"), BVF Partners OS Ltd. ("Partners OS"), BVF Partners L.P. ("Partners"), BVF Inc. and Mark N. Lampert (collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein. F4 · ownership.direct: Securities owned directly by Trading Fund OS. As the general partner of Trading Fund OS, Partners OS may be deemed to beneficially own the securities owned directly by Trading Fund OS. As the investment manager of Trading Fund OS and the sole member of Partners OS, Partners may be deemed to beneficially own the securities owned directly by Trading Fund OS. As the investment adviser and general partner of Partners, BVF Inc. may be deemed to beneficially own the securities owned directly by Trading Fund OS. As a director and officer of BVF Inc., Mr. Lampert may be deemed to beneficially own the securities owned directly by Trading Fund OS. Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 20:49 UTC |
BVF PARTNERS L P/IL10% owner
BIOTECHNOLOGY VALUE FUND L PSee Explanation of Responses
BIOTECHNOLOGY VALUE FUND II LPSee Explanation of Responses
Biotechnology Value Trading Fund OS LPSee Explanation of Responses
BVF Partners OS Ltd.See Explanation of Responses
BVF INC/IL10% owner
LAMPERT MARK N10% owner
|
PurchaseCommon Stock, $0.001 par value | 689,834 | $3.18 | $2,195,051.79 |
DisclosureSEC source: 0000921895-19-002381 · form407422010_09092019.xml · nonDerivative · entry 2 BVF PARTNERS L P/IL · CIK 0001055947 · 10% owner BIOTECHNOLOGY VALUE FUND L P · CIK 0000918923 · See Explanation of Responses BIOTECHNOLOGY VALUE FUND II LP · CIK 0001102444 · See Explanation of Responses Biotechnology Value Trading Fund OS LP · CIK 0001660683 · See Explanation of Responses BVF Partners OS Ltd. · CIK 0001660684 · See Explanation of Responses BVF INC/IL · CIK 0001056807 · 10% owner LAMPERT MARK N · CIK 0001233840 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,955,440 F1 · security: This Form 4 is filed jointly by Biotechnology Value Fund, L.P. ("BVF"), Biotechnology Value Fund II, L.P. ("BVF2"), Biotechnology Value Trading Fund OS LP ("Trading Fund OS"), BVF Partners OS Ltd. ("Partners OS"), BVF Partners L.P. ("Partners"), BVF Inc. and Mark N. Lampert (collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein. F3 · ownership.direct: Securities owned directly by BVF2. As the general partner of BVF2, Partners may be deemed to beneficially own the securities owned directly by BVF2. As the investment adviser and general partner of Partners, BVF Inc. may be deemed to beneficially own the securities owned directly by BVF2. As a director and officer of BVF Inc., Mr. Lampert may be deemed to beneficially own the securities owned directly by BVF2. Read SEC document |
| September 05, 2019 Filed Sep 9, 2019 20:49 UTC |
BVF PARTNERS L P/IL10% owner
BIOTECHNOLOGY VALUE FUND L PSee Explanation of Responses
BIOTECHNOLOGY VALUE FUND II LPSee Explanation of Responses
Biotechnology Value Trading Fund OS LPSee Explanation of Responses
BVF Partners OS Ltd.See Explanation of Responses
BVF INC/IL10% owner
LAMPERT MARK N10% owner
|
PurchaseCommon Stock, $0.001 par value | 853,956 | $3.18 | $2,717,287.99 |
DisclosureSEC source: 0000921895-19-002381 · form407422010_09092019.xml · nonDerivative · entry 1 BVF PARTNERS L P/IL · CIK 0001055947 · 10% owner BIOTECHNOLOGY VALUE FUND L P · CIK 0000918923 · See Explanation of Responses BIOTECHNOLOGY VALUE FUND II LP · CIK 0001102444 · See Explanation of Responses Biotechnology Value Trading Fund OS LP · CIK 0001660683 · See Explanation of Responses BVF Partners OS Ltd. · CIK 0001660684 · See Explanation of Responses BVF INC/IL · CIK 0001056807 · 10% owner LAMPERT MARK N · CIK 0001233840 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,639,935 F1 · security: This Form 4 is filed jointly by Biotechnology Value Fund, L.P. ("BVF"), Biotechnology Value Fund II, L.P. ("BVF2"), Biotechnology Value Trading Fund OS LP ("Trading Fund OS"), BVF Partners OS Ltd. ("Partners OS"), BVF Partners L.P. ("Partners"), BVF Inc. and Mark N. Lampert (collectively, the "Reporting Persons"). Each of the Reporting Persons is a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein. F2 · ownership.direct: Securities owned directly by BVF. As the general partner of BVF, Partners may be deemed to beneficially own the securities owned directly by BVF. As the investment adviser and general partner of Partners, BVF Inc. may be deemed to beneficially own the securities owned directly by BVF. As a director and officer of BVF Inc., Mr. Lampert may be deemed to beneficially own the securities owned directly by BVF. Read SEC document |
| August 13, 2019 Filed Aug 15, 2019 20:03 UTC |
JUNIUS DANIEL MDirector
|
PurchaseCommon Stock | 10,000 | $3.18 | $31,800.00 |
DisclosureSEC source: 0001209191-19-046095 · doc4.xml · nonDerivative · entry 1 JUNIUS DANIEL M · CIK 0001094159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Read SEC document |
| August 06, 2019 Filed Aug 7, 2019 20:29 UTC |
King Rachel K.Director · President, CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 166,759 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001209191-19-044967 · doc4.xml · derivative · entry 4 King Rachel K. · CIK 0001589712 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,821 Underlying: Common Stock · 166,759 shares Expires 2021-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares underlying this option are fully vested and exercisable. Read SEC document |
| August 06, 2019 Filed Aug 7, 2019 20:29 UTC |
King Rachel K.Director · President, CEO
|
Exercise / conversionCommon Stock | 166,759 | $1.12 | $186,770.08 |
DisclosureSEC source: 0001209191-19-044967 · doc4.xml · nonDerivative · entry 1 King Rachel K. · CIK 0001589712 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 307,144 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 17, 2019 Filed May 21, 2019 20:10 UTC |
JUNIUS DANIEL MDirector
|
GrantStock Option (right to buy) · Derivative | 21,000 | $0.00 Strike: $12.39 | $0.00 |
DisclosureSEC source: 0001209191-19-031725 · doc4.xml · derivative · entry 1 JUNIUS DANIEL M · CIK 0001094159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires 2029-05-16 F1 · derivative.exercise_date: The shares underlying this option vest on May 17, 2020, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| May 17, 2019 Filed May 21, 2019 16:11 UTC |
Andrews Patricia SDirector
|
GrantStock Option (right to buy) · Derivative | 21,000 | $0.00 Strike: $12.39 | $0.00 |
DisclosureSEC source: 0001209191-19-031734 · doc4.xml · derivative · entry 1 Andrews Patricia S · CIK 0001445710 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires 2029-05-16 F1 · derivative.exercise_date: The shares underlying this option vest on May 17, 2020, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| May 17, 2019 Filed May 21, 2019 20:08 UTC |
Koenig ScottDirector
|
GrantStock Option (right to buy) · Derivative | 21,000 | $0.00 Strike: $12.39 | $0.00 |
DisclosureSEC source: 0001209191-19-031720 · doc4.xml · derivative · entry 1 Koenig Scott · CIK 0001587514 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires 2029-05-16 F1 · derivative.exercise_date: The shares underlying this option vest on May 17, 2020, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| May 17, 2019 Filed May 21, 2019 20:06 UTC |
PEARSON TIMOTHY RDirector
|
GrantCommon Stock · Derivative | 21,000 | $0.00 Strike: $12.39 | $0.00 |
DisclosureSEC source: 0001209191-19-031718 · doc4.xml · derivative · entry 1 PEARSON TIMOTHY R · CIK 0001528617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires 2029-05-16 F1 · derivative.exercise_date: The shares underlying this option vest on May 17, 2020, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| May 17, 2019 Filed May 21, 2019 20:05 UTC |
Goldberg Mark AlanDirector
|
GrantStock Option (right to buy) · Derivative | 21,000 | $0.00 Strike: $12.39 | $0.00 |
DisclosureSEC source: 0001209191-19-031716 · doc4.xml · derivative · entry 1 Goldberg Mark Alan · CIK 0001532475 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires 2029-05-16 F1 · derivative.exercise_date: The shares underlying this option vest on May 17, 2020, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| May 17, 2019 Filed May 21, 2019 20:04 UTC |
Jackson Scott ThomasDirector
|
GrantStock Option (right to buy) · Derivative | 21,000 | $0.00 Strike: $12.39 | $0.00 |
DisclosureSEC source: 0001209191-19-031714 · doc4.xml · derivative · entry 1 Jackson Scott Thomas · CIK 0001566617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires 2029-05-16 F1 · derivative.exercise_date: The shares underlying this option vest on May 17, 2020, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| January 17, 2019 Filed Jan 22, 2019 23:22 UTC |
King Rachel K.Director · President, CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 265,000 | $0.00 Strike: $10.59 | $0.00 |
DisclosureSEC source: 0001209191-19-004827 · doc4.xml · derivative · entry 1 King Rachel K. · CIK 0001589712 · Director · President, CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,000 Underlying: Common Stock · 265,000 shares Expires 2029-01-16 F1 · derivative.exercise_date: One-fourth of the shares underlying this option vest on January 17, 2020 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date. Read SEC document |
| January 17, 2019 Filed Jan 22, 2019 23:20 UTC |
Thackray Helen M.SVP Clinical Development, CMO
|
GrantEmployee Stock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $10.59 | $0.00 |
DisclosureSEC source: 0001209191-19-004823 · doc4.xml · derivative · entry 1 Thackray Helen M. · CIK 0001589725 · SVP Clinical Development, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2029-01-16 F1 · derivative.exercise_date: One-fourth of the shares underlying this option vest on January 17, 2020 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date. Read SEC document |
| January 17, 2019 Filed Jan 22, 2019 23:21 UTC |
Magnani John L.Director · SVP of Research, CSO
|
GrantEmployee Stock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $10.59 | $0.00 |
DisclosureSEC source: 0001209191-19-004825 · doc4.xml · derivative · entry 1 Magnani John L. · CIK 0001589713 · Director · SVP of Research, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2029-01-16 F1 · derivative.exercise_date: One-fourth of the shares underlying this option vest on January 17, 2020 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date. Read SEC document |
| January 17, 2019 Filed Jan 22, 2019 23:18 UTC |
Hahn Brian M.SVP Finance, CFO
|
GrantEmployee Stock Option (right to buy) · Derivative | 90,000 | $0.00 Strike: $10.59 | $0.00 |
DisclosureSEC source: 0001209191-19-004821 · doc4.xml · derivative · entry 1 Hahn Brian M. · CIK 0001589711 · SVP Finance, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2029-01-16 F1 · derivative.exercise_date: One-fourth of the shares underlying this option vest on January 17, 2020 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 00:01 UTC |
Jackson Scott ThomasDirector
|
GrantStock Option (right to buy) · Derivative | 22,000 | $0.00 Strike: $11.52 | $0.00 |
DisclosureSEC source: 0001209191-18-060160 · doc4.xml · derivative · entry 1 Jackson Scott Thomas · CIK 0001566617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires 2028-11-26 F1 · derivative.exercise_date: This option grant was made pursuant to the issuer's non-employee director compensation policy. The shares underlying this option vest in three equal installments on November 27, 2019, 2020 and 2021, subject to the reporting person's continuous service with the issuer at each vesting date. Read SEC document |
| October 18, 2018 Filed Oct 18, 2018 21:36 UTC |
Magnani John L.Director · SVP of Research, CSO
|
SaleCommon Stock | 3,527 | $14.02 | $49,448.54 |
DisclosureSEC source: 0001209191-18-055586 · doc4.xml · nonDerivative · entry 3 Magnani John L. · CIK 0001589713 · Director · SVP of Research, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,793 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b-5 trading plan adopted by the reporting person on September 21, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 17, 2018 Filed Oct 18, 2018 21:36 UTC |
Magnani John L.Director · SVP of Research, CSO
|
SaleCommon Stock | 7,273 | $14.00 | $101,822.00 |
DisclosureSEC source: 0001209191-18-055586 · doc4.xml · nonDerivative · entry 2 Magnani John L. · CIK 0001589713 · Director · SVP of Research, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,320 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b-5 trading plan adopted by the reporting person on September 21, 2018. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| October 16, 2018 Filed Oct 18, 2018 21:36 UTC |
Magnani John L.Director · SVP of Research, CSO
|
SaleCommon Stock | 14,200 | $14.01 | $198,942.00 |
DisclosureSEC source: 0001209191-18-055586 · doc4.xml · nonDerivative · entry 1 Magnani John L. · CIK 0001589713 · Director · SVP of Research, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,593 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b-5 trading plan adopted by the reporting person on September 21, 2018. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| June 11, 2018 Filed Jun 12, 2018 21:54 UTC | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,260 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001209191-18-037288 · doc4.xml · derivative · entry 3 Hahn Brian M. · CIK 0001589711 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,260 Underlying: Common Stock · 5,260 shares Expires 2021-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Fully vested and exercisable. Read SEC document |
|
| June 11, 2018 Filed Jun 12, 2018 21:54 UTC | SaleCommon Stock | 19,345 | $18.04 | $348,983.80 |
DisclosureSEC source: 0001209191-18-037288 · doc4.xml · nonDerivative · entry 2 Hahn Brian M. · CIK 0001589711 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.80 to $18.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) to this Form 4. Read SEC document |
|
| June 11, 2018 Filed Jun 12, 2018 21:54 UTC | Exercise / conversionCommon Stock | 5,260 | $1.12 | $5,891.20 |
DisclosureSEC source: 0001209191-18-037288 · doc4.xml · nonDerivative · entry 1 Hahn Brian M. · CIK 0001589711 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,345 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| May 23, 2018 Filed May 24, 2018 21:11 UTC |
Magnani John L.Director · SVP of Research, CSO
|
Exercise / conversionWarrant to Purchase Common Stock (right to buy) · Derivative | 596 | $0.00 Strike: $0.33 | $0.00 |
DisclosureSEC source: 0001209191-18-033068 · doc4.xml · derivative · entry 4 Magnani John L. · CIK 0001589713 · Director · SVP of Research, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 596 shares Expires 2019-01-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 23, 2018 Filed May 24, 2018 21:11 UTC |
Magnani John L.Director · SVP of Research, CSO
|
Exercise / conversionWarrant to Purchase Common Stock (right to buy) · Derivative | 895 | $0.00 Strike: $0.33 | $0.00 |
DisclosureSEC source: 0001209191-18-033068 · doc4.xml · derivative · entry 3 Magnani John L. · CIK 0001589713 · Director · SVP of Research, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 895 shares Expires 2018-07-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 23, 2018 Filed May 24, 2018 21:11 UTC |
Magnani John L.Director · SVP of Research, CSO
|
Exercise / conversionCommon Stock | 1,491 | $0.33 | $492.03 |
DisclosureSEC source: 0001209191-18-033068 · doc4.xml · nonDerivative · entry 1 Magnani John L. · CIK 0001589713 · Director · SVP of Research, CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,793 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2018 Filed May 21, 2018 20:20 UTC |
JUNIUS DANIEL MDirector
|
GrantStock Option (right to buy) · Derivative | 11,000 | $0.00 Strike: $18.41 | $0.00 |
DisclosureSEC source: 0001209191-18-031836 · doc4.xml · derivative · entry 1 JUNIUS DANIEL M · CIK 0001094159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2028-05-17 F1 · derivative.exercise_date: The shares underlying this option vest on May 18, 2019, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| May 18, 2018 Filed May 21, 2018 16:14 UTC |
Andrews Patricia SDirector
|
GrantStock Option (right to buy) · Derivative | 11,000 | $0.00 Strike: $18.41 | $0.00 |
DisclosureSEC source: 0001209191-18-031812 · doc4.xml · derivative · entry 1 Andrews Patricia S · CIK 0001445710 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2028-05-17 F1 · derivative.exercise_date: The shares underlying this option vest on May 18, 2019, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| May 18, 2018 Filed May 21, 2018 16:26 UTC |
BARRETT M JAMESDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 11,000 | $0.00 Strike: $18.41 | $0.00 |
DisclosureSEC source: 0001209191-18-031858 · doc4.xml · derivative · entry 1 BARRETT M JAMES · CIK 0001219855 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2028-05-17 F1 · derivative.exercise_date: The shares underlying this option vest on May 18, 2019, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| May 18, 2018 Filed May 21, 2018 20:22 UTC |
Goldberg Mark AlanDirector
|
GrantStock Option (right to buy) · Derivative | 11,000 | $0.00 Strike: $18.41 | $0.00 |
DisclosureSEC source: 0001209191-18-031842 · doc4.xml · derivative · entry 1 Goldberg Mark Alan · CIK 0001532475 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2028-05-17 F1 · derivative.exercise_date: The shares underlying this option vest on May 18, 2019, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| May 18, 2018 Filed May 21, 2018 20:17 UTC |
Koenig ScottDirector
|
GrantStock Option (right to buy) · Derivative | 11,000 | $0.00 Strike: $18.41 | $0.00 |
DisclosureSEC source: 0001209191-18-031825 · doc4.xml · derivative · entry 1 Koenig Scott · CIK 0001587514 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2028-05-17 F1 · derivative.exercise_date: The shares underlying this option vest on May 18, 2019, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| May 18, 2018 Filed May 21, 2018 20:16 UTC |
PEARSON TIMOTHY RDirector
|
GrantStock Option (right to buy) · Derivative | 11,000 | $0.00 Strike: $18.41 | $0.00 |
DisclosureSEC source: 0001209191-18-031817 · doc4.xml · derivative · entry 1 PEARSON TIMOTHY R · CIK 0001528617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,000 Underlying: Common Stock · 11,000 shares Expires 2028-05-17 F1 · derivative.exercise_date: The shares underlying this option vest on May 18, 2019, subject to the reporting person's continuous service as of such vesting date. Read SEC document |
| May 10, 2018 Filed May 11, 2018 21:01 UTC |
BARRIS PETER J10% owner
|
OtherWarrant to Purchase Common Stock (right to buy) · Derivative | 298,406 | $0.00 Strike: $0.33 | $0.00 |
DisclosureSEC source: 0001209191-18-029616 · doc4.xml · derivative · entry 7 BARRIS PETER J · CIK 0001005561 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 1 Disclosed balance after: 0 Underlying: Common Stock · 298,406 shares Expires 2019-01-16 F1 · ownership.nature: The Reporting Person is a general partner of NEA Partners 10, Limited Partnership ("NEA Partners 10"), NEA Partners 10 is the sole general partner of New Enterprise Associates 10, Limited Partnership ("NEA 10"), the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 10 shares in which the Reporting Person has no pecuniary interest. Read SEC document |
| May 10, 2018 Filed May 11, 2018 21:01 UTC |
BARRIS PETER J10% owner
|
OtherWarrant to Purchase Common Stock (right to buy) · Derivative | 216,046 | $0.00 Strike: $0.33 | $0.00 |
DisclosureSEC source: 0001209191-18-029616 · doc4.xml · derivative · entry 6 BARRIS PETER J · CIK 0001005561 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 1 Disclosed balance after: 0 Underlying: Common Stock · 216,046 shares Expires 2018-07-03 F1 · ownership.nature: The Reporting Person is a general partner of NEA Partners 10, Limited Partnership ("NEA Partners 10"), NEA Partners 10 is the sole general partner of New Enterprise Associates 10, Limited Partnership ("NEA 10"), the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 10 shares in which the Reporting Person has no pecuniary interest. Read SEC document |
| May 10, 2018 Filed May 11, 2018 21:01 UTC |
BARRIS PETER J10% owner
|
SaleCommon Stock | 5,533 | $17.81 | $98,542.73 |
DisclosureSEC source: 0001209191-18-029616 · doc4.xml · nonDerivative · entry 4 BARRIS PETER J · CIK 0001005561 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 1 Disclosed balance after: 4,995,664 F3 · kind: On May 10, 2018, NEA 10 exercised warrants to purchase a total of 298,406 shares of the Issuer's common stock for $0.33 a share. NEA 10 paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 5,533 of the warrant shares to pay the exercise price and issuing 292,873 shares to NEA 10. The Issuer also paid cash to NEA 10 in lieu of any fractional shares to be issued upon exercise of the warrants. F1 · ownership.nature: The Reporting Person is a general partner of NEA Partners 10, Limited Partnership ("NEA Partners 10"), NEA Partners 10 is the sole general partner of New Enterprise Associates 10, Limited Partnership ("NEA 10"), the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 10 shares in which the Reporting Person has no pecuniary interest. Read SEC document |
| May 10, 2018 Filed May 11, 2018 21:01 UTC |
BARRIS PETER J10% owner
|
OtherCommon Stock | 298,406 | $0.33 | $98,473.98 |
DisclosureSEC source: 0001209191-18-029616 · doc4.xml · nonDerivative · entry 3 BARRIS PETER J · CIK 0001005561 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · See Note 1 Disclosed balance after: 5,001,197 F1 · ownership.nature: The Reporting Person is a general partner of NEA Partners 10, Limited Partnership ("NEA Partners 10"), NEA Partners 10 is the sole general partner of New Enterprise Associates 10, Limited Partnership ("NEA 10"), the direct beneficial owner of the shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the NEA 10 shares in which the Reporting Person has no pecuniary interest. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.